AIG vs MYGN · P/E 21, rev $13.73B vs rev $837.6M
American International Group Inc (AIG) versus Myriad Genetics Inc (MYGN) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
Latest reported AIG revenue for 2026-06-30 was $13.73B. Net income was $1.71B. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
Latest reported MYGN revenue for 2024-12-31 was $837.6M. Net income was -$127.3M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. MYGN currently screens at market cap $413.7M.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. MYGN currently screens at market cap $413.7M.
Not investment advice. Open the AIG and MYGN stock pages for the full models.
Not investment advice.